(Q36929295)

17 August 2017

Intermittent versus continuous androgen deprivation in prostate cancer (English)

1 reference

17 August 2017

1 reference

7

George Wilding

1 reference

17 August 2017

4

Celestia S Higano

1 reference

17 August 2017

2

Catherine M Tangen

1 reference

17 August 2017

Maha Hussain

1

1 reference

17 August 2017

Donna L Berry

3

1 reference

17 August 2017

E David Crawford

5

1 reference

17 August 2017

Glenn Liu

6

1 reference

17 August 2017

Stephen Prescott

8

1 reference

17 August 2017

Subramanian Kanaga Sundaram

9

1 reference

17 August 2017

Eric Jay Small

10

1 reference

17 August 2017

Nancy Ann Dawson

11

1 reference

17 August 2017

Bryan J Donnelly

12

1 reference

17 August 2017

Peter M Venner

13

1 reference

17 August 2017

Ulka N Vaishampayan

14

1 reference

17 August 2017

Paul F Schellhammer

15

1 reference

17 August 2017

David I Quinn

16

1 reference

17 August 2017

Derek Raghavan

17

1 reference

17 August 2017

Benjamin Ely

18

1 reference

17 August 2017

Carol M Moinpour

19

1 reference

17 August 2017

Nicholas J Vogelzang

20

1 reference

17 August 2017

Ian M Thompson

21

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

The New England Journal of Medicine

17 August 2017

1 reference

17 August 2017

368

1 reference

17 August 2017

14

1 reference

17 August 2017

1314-1325

1 reference

Intermittent androgen suppression for rising PSA level after radiotherapy

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Safety and tolerability of intermittent androgen deprivation therapy: a literature review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Should intermittent androgen deprivation be used in routine clinical practice?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Toxicity and response criteria of the Eastern Cooperative Oncology Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Quality of life assessment in Southwest Oncology Group trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Mechanisms of androgen-refractory prostate cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Pattern mixture models for longitudinal quality of life studies in advanced stage disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3682658

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

4 September 2018

1 reference

12 December 2020

Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report

1 reference

12 December 2020

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study

1 reference

12 December 2020

Experimental treatment of prostatic cancer by intermittent hormonal therapy

1 reference

12 December 2020

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma

1 reference

12 December 2020

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA1212299

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23550669

1 reference